GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC reminded investors of the August 3, 2026 deadline to file lead plaintiff applications in a securities class action against GeneDx Holdings. The lawsuit alleges that the company failed to disclose material information regarding the performance of its Fabric Genomics acquisition and subsequent revenue guidance cuts.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.